In 2007, Morgunov
LIu and his collaborators publish a study among
49 patients having received testosterone
undecanoate without interruption during one year
for erectile insufficiency. There was no
prostatic disorder for patients carrying an
adenoma and there was no trace of a beginning
prostate cancer.
Download pdf.(2)
En 2012,
Feneley
MR,
Carruthers MR publish a study on the
detection of prostate cancer in 1365 men (old
from 28 to 87 years -average age 55 years)
treated continuously with androgens for one
period going back sometimes to 20 years. They
concluded that the monitoring of the prostate
under continuous treatment with androgens is
safe and improves early detection of prostate
cancer whose frequency is the same one as in the
whole of the population.
Download pdf. (3).
In 2012,
Aversa A and its collaborators show the
beneficial effects of testosterone on the
osseous density. 60 men (average age 57± 10)
were
treated for 36 months without interruption
with testosterone without causing
side-effect.(4).
In 1994, Gooren demonstated the safety
with androgens' therapy. (5)
Download pdf.
.png){kind=small}
